Science
Susan F. Wood, Who Quit F.D.A. Over Contraception Pill Delay, Dies at 66

Susan F. Wood, a women’s health expert who resigned in protest from the Food and Drug Administration in 2005, accusing the agency of knuckling under to politics by not approving over-the-counter sales of the morning-after pill known as Plan B, died on Jan. 17 at her home in London. She was 66.
The cause was the brain cancer glioblastoma multiforme, said Richard Payne, her husband.
Dr. Wood was assistant commissioner for women’s health at the F.D.A. during the presidency of George W. Bush when Plan B, a form of emergency contraception, became a flashpoint in the abortion wars.
An F.D.A. advisory panel voted 28-0 in 2003 that the pill was safe for nonprescription use. But senior agency officials disregarded precedent and refused to approve over-the-counter sales.
Plan B contains high levels of progestin, a hormone found in ordinary birth control pills, and agency scientists considered it to be a contraceptive. But abortion opponents argued that its use was tantamount to ending pregnancies. They further warned that ready access would lead to promiscuous behavior by teenagers, though no data supported that claim.
Dr. Wood and others believed that having emergency contraception available without a prescription would mean fewer unwanted pregnancies and fewer abortions.
In August 2005, the F.D.A. commissioner, Lester M. Crawford, announced that the agency could not reach a decision on whether to authorize over-the-counter use of Plan B and did not expect to reach one soon.
Dr. Wood blamed politics for the agency’s foot-dragging and resigned from a job she had held for five years. In an email to the staff, she wrote that she could no longer remain “when scientific and clinical evidence, fully evaluated and recommended for approval by the professional staff here, has been overruled.”
A report later that year by the Government Accountability Office, the nonpartisan investigative arm of Congress, found that top agency officials had rejected over-the-counter sales even before the scientific review of Plan B was complete. Officials disputed the findings.
Dr. Wood addressed the American Association for the Advancement of Science in 2006 and received a standing ovation. She criticized the F.D.A. for ignoring science because “social conservatives have extreme undue influence.”
Susan Franklin Wood was born on Nov. 5, 1958, in Jacksonville, Fla., one of four children of Dr. Jonathan Wood, a surgeon, and Betty (Dorscheid) Wood.
She graduated from the Episcopal School of Jacksonville in 1976 and Southwestern at Memphis (now Rhodes College) in 1980. After earning a Ph.D. in biology from Boston University in 1989, she shifted her focus to health policy.
In 1990, she received a fellowship as a science adviser to the Congressional Caucus for Women’s Issues, a bipartisan group. Over five years on Capitol Hill, she helped push legislation to increase the representation of women in clinical trials and to expand research into breast cancer, infertility and contraception.
In 1995 she became policy director in the Office on Women’s Health, part of the Department of Health and Human Services. She joined the F.D.A. in 2000 to lead the women’s health department.
Objections to approving Plan B for over-the-counter sales zeroed in on whether it should be available to younger teenagers. The manufacturer, Barr Laboratories, proposed restricting sales to people 16 and up.
A senior F.D.A. official told Dr. Wood that the drug was on track to win nonprescription approval for those 17 and older, Dr. Wood recalled in an oral history that she recorded for the agency in 2019.
“I heard that with my own little ears,” she said. “And everyone was waiting for the decision to come out, silently.”
“But,” she added, “the decision never came out.”
On a Friday afternoon, Dr. Crawford announced that an age restriction for over-the-counter sales would be hard for pharmacies to manage. The issue, he said, needed more study. In the meantime, nonprescription use was not approved for anyone.
Dr. Wood quit the next Tuesday. She expected her decision to go mostly unnoticed. Instead, the news media instantly reported on it.
“I ended up spending the next eight months really just traveling and speaking about this,” she said. “It affected the perception of whether or not you could trust government at the time.”
In 2006, Dr. Wood joined the Milken Institute School of Public Health at George Washington University as a research professor. She became a full professor in 2017 and directed the Jacobs Institute of Women’s Health there. She and her husband moved to the Isle of Mull in Scotland in 2017, with a second residence in London; she continued to teach remotely until she retired in 2022.
Besides her husband, she is survived by a daughter, Bettie Wood Payne.
The contretemps over Plan B faded, overshadowed by more contentious episodes of abortion politics. Plan B finally won over-the-counter approval in 2013, though some states allow pharmacists to refuse to dispense it.
In 2019, Dr. Wood said fears that easy access to a morning-after pill would be a “dangerous, radical, crazy” thing proved to be overblown.
“Once it’s over the counter, it’s no big deal,” she said. “And, sure enough, that’s what happened. It’s no big deal.”

Science
Video: SpaceX Launches NASA’s Crew-10 Mission

new video loaded: SpaceX Launches NASA’s Crew-10 Mission
transcript
transcript
SpaceX Launches NASA’s Crew-10 Mission
The mission would allow Suni Williams and Butch Wilmore, two NASA astronauts, to return to Earth. Their brief scheduled visit to the space station last June was unexpectedly stretched to more than nine months.
-
“Ignition and liftoff.” [cheering] “[unclear] and liftoff as Crew-10 now soaring to International Space Station.” “Great callouts and incredible views there on your left-hand screen. In your left-hand screen, you can see a view from Stage 1.” [cheering] “The first stage making its way back down to Earth, and the second stage continuing to fire.” [cheering] “There, on the right-hand side of your screen, you can see some first images of Crew-10 inside the Dragon Endurance spacecraft, as they’re now successfully in orbit.”
Recent episodes in Science
Science
Photos Show Blood Moon Lunar Eclipse Around the World

From Thursday night into Friday morning, the Earth’s shadow gradually overtook the moon’s typically bright white face, which took on a ruddy red hue. It was the first total lunar eclipse, also known as a blood moon, in more than two years.
A lunar eclipse occurs when the sun, Earth and moon align, in that order. There are different types of lunar eclipses, but total lunar eclipses cause the moon to shine red because sunlight must travel through the atmosphere before illuminating the moon. Blue wavelengths of light scatter more readily in our atmosphere, but redder wavelengths pass through, creating the blood-moon effect.
The blood moon was most visible this week in the Americas, western parts of Africa and Europe, New Zealand and some of Russia.
Local stargazing groups and planetariums in many cities hosted watch parties, while others got the chance to see it online. Totality, when the entire moon is engulfed in the darkest part of Earth’s shadow, was expected at 2:25 a.m. Eastern.
But anyone who missed it won’t have to wait long for another chance. Lunar eclipses can occur several times a year, though not all of them reach totality. According to NASA, the next total lunar eclipse will occur in September, most visible in Asia and parts of Europe, Africa and Australia. There will be another total lunar eclipse next March, followed by a partial lunar eclipse in August 2026.
Humanity’s well-documented and ancient fascination with the Earth’s only natural satellite means that stargazers across the planet last night participated in an activity as old as time: They turned their eyes to the sky. Here’s what that looked like in different locations around the world:
Katrina Miller contributed reporting.
Science
Video Shows Mars and Deimos Close Up During ESA’s Hera Flyby

An asteroid-chasing spacecraft just swung past Mars on Wednesday. As it zipped by, it took hundreds of shots of the Red Planet, as well as several snaps of Deimos, one of the two small Martian moons.
The operators of the European Space Agency’s Hera spacecraft were bewitched by the sci-fi aesthetics of the pictures.
“We were waiting with impatience to get these images,” said Patrick Michel, the principal investigator for Hera, during a Thursday news conference at mission control in Darmstadt, Germany. When the first shots of the moon appeared, many of the Hera team members burst into cheers. “We’ve never seen Deimos in that way,” Dr. Michel said.
Navigators managed to fly Hera about 600 miles above Deimos, a craggy moon just nine miles long. The pass shows the object in remarkable detail — a small island gliding above the crater-scarred Martian desert.
During the news conference, Ian Carnelli, the Hera project manager, was misty-eyed. “I’m going to get emotional,” he said. “The excitement was such that we didn’t get any sleep.”
Hera was using Mars in what is known as a gravity assist, both accelerating the spacecraft and adjusting its flight path. But its mission operators also wanted to take advantage of the Martian flyby and use it to test the mechanical eyes that will allow Hera to study the asteroid it is targeting, Dimorphos.
In the coming days, the mission’s scientists will reveal more photographs from Hera’s encounter with Mars, which may include shots of Phobos, the planet’s other moon.
As with any planetary flyby, there were some nerves about whether Hera would conduct its maneuvers properly and end up on the right trajectory. “The spacecraft behaved very well,” said Sylvain Lodiot, the Hera operations manager. “We’re on track to the asteroid system.”
Hera is headed to Dimorphos as a follow-up to a 2022 NASA mission, the Double Asteroid Redirection Test. DART deliberately crashed a spacecraft into that asteroid, aiming to change its orbit around a larger asteroid, Didymos. That was a test of whether a dangerous space rock bound for Earth could be deflected in a similar manner.
The experiment successfully changed the orbit of Dimorphos. But the asteroid’s physical nature, and its full response to DART’s collision, remains unclear; some evidence suggests that it acted like a fluid when hit, rather than a solid, causing it to eject a lot of debris and reshape itself.
When it comes to stopping lethal asteroids from striking Earth, the more scientists know about their rocky enemies, the better prepared they will be should one come careening our way. To aid that effort, the European Hera mission will arrive at Dimorphos in late 2026 for a close-up study of the DART-impacted asteroid.
This Wednesday, during Hera’s flyby of Mars and Deimos, the spacecraft used three cameras — including a thermal infrared imager supplied by the Japan Aerospace Exploration Agency.
Mars’s two moons have mysterious origins. Both could be pieces of a disintegrating asteroid captured by the planet’s gravity, or perhaps the flotsam and jetsam leftover from a giant impact event on Mars.
Deimos is tidally locked, meaning one hemisphere permanently faces Mars. This near side is the one most commonly seen by spacecraft orbiting the planet, or by rovers driving across its surface. Hera managed to fly behind Deimos, meaning it caught a rare sight.
“It’s one of the very few images we have of the far side of Deimos,” said Stephan Ulamec, a researcher at the German Aerospace Center and member of the Hera team.
This opportunistic peek at Mars and Deimos was exciting. But the team is especially thrilled that Hera is now on its way to its asteroid destination. “We’re all looking forward to what Didymos and Dimorphos will look like,” Dr. Michel said.
-
News7 days ago
Gene Hackman Lost His Wife and Caregiver, and Spent 7 Days Alone
-
Politics7 days ago
Republicans demand Trump cut American legal association out of nominee process
-
Politics1 week ago
Agriculture secretary cancels $600K grant for study on menstrual cycles in transgender men
-
News7 days ago
States sue Trump administration over mass firings of federal employees
-
Movie Reviews1 week ago
‘Black Bag’ Review: Cate Blanchett and Michael Fassbender Cozy Up in Steven Soderbergh’s Snazzy Spy Thriller
-
News1 week ago
Who Paid for Trump’s Transition to Power? The Donors Are Still Unknown.
-
News1 week ago
Trump Seeks to Bar Student Loan Relief to Workers Aiding Migrants and Trans Kids
-
Politics1 week ago
Kristi Noem says 2 leakers accused of disclosing ICE operations ID'd: 'Put law enforcement lives in jeopardy'